Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00446953
Status:
COMPLETED
Last Update Posted:
2015-10-14
First Post:
2007-03-12
Brief Title:
Caesarean and Corticotherapy
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Interest in Programming Caesarean Section at 38 Weeks of Pregnancy With Antenatal Betamethasone to Prevent Neonatal Respiratory Distress and to Avoid Emergency Caesarean Section Before Planned Date
Status:
COMPLETED
Status Verified Date:
2013-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Comparison of two randomized group
caesarean section planned at 38 weeks after 2 antenatal injections of 12 mg of betamethasone 48 h before
caesarean section planned at 39 weeks without corticosteroid
The aim is to demonstrate that programming caesarean section at 38 weeks of pregnancy after antenatal corticosteroid allows to avoid caesarean section in emergency because of a labour before 39 weeks without increasing the neonatal respiratory distress rate
caesarean section planned at 38 weeks after 2 antenatal injections of 12 mg of betamethasone 48 h before
caesarean section planned at 39 weeks without corticosteroid
The aim is to demonstrate that programming caesarean section at 38 weeks of pregnancy after antenatal corticosteroid allows to avoid caesarean section in emergency because of a labour before 39 weeks without increasing the neonatal respiratory distress rate
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None